- Home
- MRK vs BPOPM Comparison
MRK vs BPOPM Comparison
Compare MRK & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | BPOPM |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | BPOPM |
|---|---|---|
| Price | $108.21 | $25.45 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $114.86 | N/A |
| AVG Volume (30 Days) | ★ 11.3M | N/A |
| Earning Date | 02-03-2026 | N/A |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | N/A |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $14.32 | ★ N/A |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | N/A |
| 52 Week High | $112.90 | N/A |
Technical Indicators
Market Signals| Indicator | MRK | BPOPM |
|---|---|---|
| Relative Strength Index (RSI) | 54.86 | 53.07 |
| Support Level | $106.93 | $25.43 |
| Resistance Level | $111.97 | $25.65 |
| Average True Range (ATR) | 2.76 | 0.14 |
| MACD | -0.45 | -0.00 |
| Stochastic Oscillator | 33.80 | 66.67 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About BPOPM Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities
Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.